Linda Franchini, MD
- 5Articles
- 11.6KReads
- 1997–2021Active
- 11Collaborators
About
Linda Franchini, MD, is affiliated with the IRCCS San Raffaele Scientific Institute, Mood Disorders Unit, in Milan, Italy. Since 1997, Franchini has published research focusing on major depressive disorder, including studies on antidepressant treatments such as venlafaxine, fluvoxamine, citalopram, paroxetine, and sertraline for prevention and maintenance therapy. More recently, Franchini has explored clinical implications of COVID-19 in psychiatric inpatients. Frequent collaborators include Enrico Smeraldi, Raffaella Zanardi, and Jorge Perez.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
